Mometasone furoate monohydrate 141646-00-6 98%

As an Active Pharmaceutical Ingredients (APIs) manufacturing company, we develop innovative pharma solutions and leverage our collective expertise to improve patient health. Based out of Indore, Central India, Symbiotec develops, produces, and markets research-based Cortico-Steroids and Steroid-Hormone APIs.

In pursuit of a healthier world for everyone to live in, we deliver reliable access to healthcare solutions and advanced sustainable operations.

This goal of ours shapes our strategy and governs our every operation. From research and development (R&D) to the transfer of knowledge to stakeholders, we offer innovative health solutions.

Since the inception of our R&D and pilot-scale operations in 1995, we have continually adapted the way we respond to the dynamic marketplace. We have always exhibited a readiness to change with the frequently evolving technology and route of synthesis in the Active Pharmaceuticals Ingredients (API) Industry.

Our work at a commercial scale started in 2004 after the commissioning of our manufacturing facility in Rau, Indore. We have since then established ourselves as a leading provider in the Cortico–Steroid and Steroid–Hormone Active Pharmaceutical Ingredient (API) segment. Symbiotec takes great pride in being a WHO-GMP, ISO 9000:2000, US FDA and EU GMP certified API Manufacturing company.

Having served the Global Pharmaceutical Industry of Steroid APIs for over two decades, we have achieved this distinction with our commitment to quality, efficiency, flexibility and cost competitiveness.